Drug Profile
Research programme: insulin-like growth factor therapeutics - Chlorogen
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chlorogen
- Class
- Mechanism of Action Insulin-like growth factor I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Liver disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-disorders in USA (Parenteral)
- 30 Jul 2007 Insulin-like growth factor therapeutics are available for licensing worldwide (http://www.chlorogen.com)